Carglumic Acid

CAS 1188-38-1 5 current recordsSmall Molecule

Who holds supplier records for Carglumic Acid? 5 organisations hold a current record for Carglumic Acid: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: Italy (2), Switzerland (1), United States (1) and India (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Carglumic Acid: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/carglumic-acid

Reading the evidence

  • 5 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (5)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Carglumic Acid. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Carglumic Acid sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (3 listed products contain Carglumic Acid). The latest listed exclusivity runs to 22 Jan 2028. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Carglumic acid is an orphan drug for the treatment of hyperammonemia, due to N-acetylglutamate synthase deficiency. It works by activating the enzyme carbamoyl phosphate synthetase, which is a part of the urea cycle.

Chemical identity

IUPAC name
(2S)-2-(carbamoylamino)pentanedioic acid
Canonical SMILES
C(CC(=O)O)[C@@H](C(=O)O)NC(=O)N
InChIKey
LCQLHJZYVOQKHU-VKHMYHEASA-N
Synonyms
Carbaglu API, carbaglu, l-glutamic acid, n-(aminocarbonyl)-, n-carbamyl-l-glutamic acid, nsc-760124, oe 312, oe-312

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Carbamoyl Phosphate Synthetase 1 Activator
Mechanism of action
Carbamoyl Phosphate Synthetase 1 Activators

Therapeutic areas

Metabolic DisordersGenetic DisordersUrea Cycle Disorders

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Carglumic Acid?

5 organisations hold an active US FDA Type II Drug Master File or a CEP for Carglumic Acid: DIPHARMA SA (Switzerland), NOVITIUM PHARMA LLC (United States), PROCOS SPA (Italy), RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA (Italy) and Scl Lifesciences Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Carglumic Acid Drug Master Files are active?

DIPHARMA SA (DMF 39329), NOVITIUM PHARMA LLC (DMF 33166), PROCOS SPA (DMF 38477), RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA (DMF 26955) and Scl Lifesciences Limited (DMF 40884). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Carglumic Acid supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Carglumic Acid?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.